Endemic infectious diseases of Afghanistan

Clinical Infectious Diseases

Volumn 34, Issue , 2002, Pages S171-S207

  Wallace, Mark R ^a   Hale, Braden R ^a   Utz, Gregory C ^a   Olson, Patrick E ^a   Earhart, Kenneth C ^c   Thornton, Scott A ^a   Hyams, Kenneth C ^b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c Naval Medical Research Unit Number 3   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

AFGHANISTAN; EMPLOYEE; ENDEMIC DISEASE; EPIDEMIC; HUMAN; INFECTION; MEDICAL LITERATURE; PRIORITY JOURNAL; REFUGEE; REVIEW; SOLDIER; WAR;

AFGHANISTAN; ANIMALS; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; ENDEMIC DISEASES; HUMANS;

EID: 0037097668     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/340704     Document Type: Review

References (349)

1. Afghanistan
2. Malnutrition and mortality in Kohistan District, Afghanistan
3. Beaten by the bugs: The Soviet-Afghan War experience
4. Medical losses of Soviet troops during the war in Afghanistan. 3: The medical losses from infectious diseases
5. Malaria among United States troops in Somalia
6. Diarrheal disease among military personnel during Operation Restore Hope, Somalia, 1992-1993
7. Dengue fever in US troops during Operation Restore Hope, Somalia, 1992-1993
8. Dengue fever in US military personnel in Haiti
9. Endemic infectious diseases of the Middle East
10. Endemic infectious diseases and biological warfare during the Gulf War: A decade of analysis and final concerns
11. In the borderland between health and disease following the Gulf War
12. Is there a Persian Gulf War syndrome? Evidence from a large population-based survey of veterans and nondeployed controls
13. War syndromes and their evaluation: From the US Civil War to the Persian Gulf War
14. Plasmodium species (malaria)
15. Malaria in travelers: Epidemiology, disease, and prevention
16. Disease and dislocation: The impact of refugee movements on the geography of malaria in NWFP, Pakistan
17. Malaria control in Afghan refugee camps: Novel solutions
18. Malaria control: Bednets or spraying? Malaria control in the Afghan refugee camps of western Pakistan
19. Pyrethroid-impregnated bednets for personal protection against malaria for Afghan refugees
20. History of malaria in the United States naval forces at war: World War I through the Vietnam conflict
21. Malaria. Part 1: Lessons from Somalia and General Slim
22. Malaria imported to the United States from Vietnam: Chemoprophylaxis evaluated in returning soldiers
23. Importation of malaria into the USSR from Afghanistan, 1981-89
24. Resistance of Plasmodium falciparum malaria to chloroquine is widespread in eastern Afghanistan
25. Transmission and control of vivax malaria in Afghan refugee settlements in Pakistan
26. Chloroquine resistance in Pakistan and the upsurge of falciparum malaria in Pakistani and Afghan refugee populations
27. Permethrin-treated chaddars and top-sheets: Appropriate technology for protection against malaria in Afghanistan and other complex emergencies
28. Epidemic malaria - Tadjikistan, 1995
29. War in Tajikistan and re-emergence of Plasmodium falciparum
30. Chloroquine-resistant Plasmodium falciparum: Now in Pakistani Punjab
31. The first case of Plasmodium falciparum resistant to chloroquine treatment discovered in the Republic of Afghanistan
32. Resistance of falciparum malaria to chloroquine and sulfadoxine-pyrimethamine in Afghan refugee settlements in western Pakistan: Surveys by the general health services using a simplified in vivo test
33. Prevalence and clinical presentation of glucose-6-phosphate dehydrogenase deficiency in Pakistani Pathan and Afghan refugee communities in Pakistan; implications for the use of primaquine in regional malaria control programmes
34. Randomized controlled trials of 5- and 14-days primaquine therapy against relapses of vivax malaria in an Afghan refugee settlement in Pakistan
35. Malaria
36. Diagnosis, treatment, and prevention of malaria
37. Falciparum malaria
38. Malaria therapy
39. Severe and complicated malaria
40. Malaria prevention
41. Tolerability of prophylactic Lariam regimens
42. Tolerance of mefioquine by Swissair trainee pilots
43. Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: Comparison with mefloquine, doxycycline, and chloroquine plus proguanil
44. Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria
45. Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Jaya, Indonesia
46. Double-blind, randomized, placebo-controlled assessment of chloroctuine/primaquine prophylaxis for malaria in nonimmune Colombian soldiers
47. An entomological investigation of the likely impact of cattle ownership on malaria in an Afghan refugee camp in the North West Frontier Province of Pakistan
48. Failure of passive zooprophylaxis: Cattle ownership in Pakistan is associated with a higher prevalence of malaria
49. Prevalence of malaria in Afghan refugee villages in Pakistan sprayed with lambdacyhalothrin or malathion
50. Malaria control using permethrin applied to tents of nomadic Afghan refugees in northern Pakistan
51. Self-protection from malaria vectors in Pakistan: An evaluation of popular existing methods and appropriate new techniques in Afghan refugee communities
52. Sustainability of pyrethroid-impregnated bednets for malaria control in Afghan communities
53. A randomized controlled trial of insecticide-treated bednets and chaddars or top sheets, and residual spraying of interior rooms for prevention of cutaneous leishmaniasis in Kabul, Afghanistan
54. Malaria: Epidemiology and prevention of exposure
55. Insect repellents
56. Advice for travelers
57. Mosquitoes and mosquito repellents: A clinician's guide
58. Mortality rates, causes of death, and health status among displaced and resident populations of Kabul, Afghanistan
59. Water distribution system and diarrheal disease transmission: A case study in Uzbekistan
60. Shigellosis and other acute intestinal infections in the Republic of Tajikistan: The epidemiological patterns
61. An analysis of the causes of intestinal infection morbidity among military personnel
62. Cholera in children in Karachi from 1990 through 1995: A study of cases admitted to a tertiary care hospital
63. The present status of cholera infection in Pakistan
64. The 1965 cholera outbreak in Afghanistan
65. Cholera on the Caspian
66. A study on prevalence of bacterial diarrhea and its agents
67. Gastroenteritis due to Vibrio cholerae El Tor Ogawa
68. Cholera admissions in adults 1989-1994: A hospital based study
69. Outbreak of gastroenteritis in different areas of Pakistan
70. An outbreak of cholera (El Tor) in Samarkand Province, Uzbekistan in 1990
71. Vibrio cholerae O139 in Karachi, Pakistan
72. Public health in Afghanistan plunges to new depths
73. The diagnostic and treatment characteristics of El Tor cholera and its combinations with other enteric disease
74. The epidemiological characteristics of the spread of Grigor'ev-Shiga dysentery in the territories of the former USSR in recent years
75. Diarrhea in children of West Pakistan: Occurrence of bacterial and parasitic agents
76. Early child health in Lahore, Pakistan: VIII
77. Etiology of acute diarrhoea among children in developing countries: A multicentre study in five countries
78. Childhood diarrhoea in Karachi
79. Acute gastroenteritis caused by E. coli O157:H7 in Pakistani children
80. Occurrence and susceptibility to antibiotics of Shigella species in stools of hospitalized children with bloody diarrhea in Pakistan
81. Antibiotic susceptibilities and plasmid profiles of Shigella flexneri isolates from children with diarrhoea in Islamabad, Pakistan
82. Causative agents of acute diarrhoea in the first 3 years of life: Hospital-based study
83. The spread of rotavirus gastroenteritis in the Republic of Tajikistan
84. Diarrheal disease during Operation Desert Shield
85. Prevalence of intestinal parasites in diarrhoeal patients
86. Treating dysentery with metronidazole in Pakistan
87. Cryptosporidium infection in young children with diarrhea in Rawalpindi, Pakistan
88. Clinical and laboratory characteristics of Cryptosporidiosis in Turkmenistan
89. Cyclospora species - A cause of diarrhoea among Irish travellers to Asia
90. A clinical trial of oral therapy in a rural cholera-treatment center
91. Vibrio cholerae serogroups O1 and O139
92. Home management of childhood diarrhoea in rural Afghanistan: A study in Urgun, Paktika Province
93. Use of azithromycin for the treatment of campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent
94. Cholera vaccines
95. Typhoid and paratyphoid fevers
96. A massive epidemic of multidrug-resistant typhoid fever in Tajikistan associated with consumption of municipal water
97. Typhoid and paratyphoid fevers
98. Comparative yield of Salmonella typhi from blood and bone marrow cultures in patients with fever of unknown origin
99. Widal agglutination test - 100 years later: Still plagued by controversy
100. Specificity of Widal test in healthy blood donors and patients with meningitis
101. Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever
102. Enteric fever treatment failures: A global concern
103. Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom
104. Quinolone-resistant Salmonella typhi in Vietnam
105. Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan
106. Short course chemotherapy with cefixime in children with multidrug-resistant Salmonella typhi septicaemia
107. Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance
108. Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children
109. Reduction of mortality in chloramphenicol-treated severe typhoid fever by high-dose dexamethasone
110. Considerations regarding mass vaccination against typhoid fever as an adjunct to sanitation and public health measures: Potential use in an epidemic in Tajikistan
111. Why are typhoid vaccines not recommended for epidemic typhoid fever?
112. Viral hepatitis
113. Viral hepatitis in the United States Army
114. Seroepidemiology of hepatitis C and B in an urban VA medical center
115. Action urged to stem hepatitis C
116. The etiological structure and epidemiological characteristics of viral hepatitis among servicemen
117. Epidemiological health surveillance among the troops during combat operations in armed conflicts
118. The prevention of intestinal anthroponoses among military personnel
119. Hepatitis A, B, and C seroprevalence in Pakistan
120. Sero-diagnosis for viral hepatitis in 93 patients admitted with acute hepatitis in three different teaching hospitals in Lahore
121. Evaluation of blood bank practices in Karachi, Pakistan, and the government's response
122. Seroprevalence of the antibody to hepatitis C in select groups in the Punjab region of Pakistan
123. Low risk of sexual transmission of hepatitis C virus in Somalia
124. Characteristics of viral hepatitis non-A, non-B with a fecal-oral mechanism of transmission of the infection in southern Uzbekistan
125. Epidemiological diagnosis of fecal-oral hepatitis E in Tajikistan
126. Exposer rate of hepatitis E (IgG) in a selected population of children and adults in Karachi
127. The enterically transmitted non-A, non-B hepatitis
128. Water-borne hepatitis E virus epidemic in Islamabad, Pakistan: A common source outbreak traced to the malfunction of a modern water treatment plant
129. Viral hepatitis in the United States Navy and Marine Corps
130. Viral hepatitis in the US Navy, 1975-1984
131. Hospital hepatitis C viral hepatitis in the US military: A study of hospitalization records from 1974 to 1999
132. The risk of human T cell leukemia virus and viral hepatitis infection among US Marines stationed in Okinawa, Japan
133. Risk of viral hepatitis among military personnel assigned to US Navy ships
134. Heterosexual transmission of viral hepatitis and cytomegalovirus among US military personnel stationed in the western Pacific
135. The risk of hepatitis C virus infection in the US military: A serosurvey of 21,000 troops
136. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
137. An outbreak of type A viral hepatitis at the Naval Training Center, San Diego: Epidemiologic evaluation
138. Hepatitis E seroconversion in United States travelers abroad
139. The unique riverine ecology of hepatitis E virus transmission in Southeast Asia
140. The impact of infectious diseases on the Health of US troops deployed to the Persian Gulf during Operations Desert Shield and Desert Storm
141. The threat of hepatitis E virus infection in Somalia during Operation Restore Hope
142. Changing patterns of drug use among US military recruits before and after enlistment
143. Update: Recommendations to prevent hepatitis B virus transmission - United States
144. The risk of transfusion-transmitted viral infections
145. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease
146. Outbreak of hepatitis C associated with intravenous immunoglobulin administration - United States, October 1993-June 1994
147. A four-year review of patients with hepatitis C antibody in Department of Veterans Affairs facilities
148. VHA hepatitis C costs placed at $250 million
149. An epidemic of hepatitis D in the foothills of the Himalayas in south Kashmir
150. Prevalence of hepatitis G virus in Pakistani children with transfusion dependent beta-thalassemia major
151. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team
152. Prevalence of sand fly fever, West Nile, Crimean-Congo hemorrhagic fever, and leptospirosis antibodies in Pakistani military personnel
153. Peginterferon Alfa-2a in patients with chronic hepatitis C
154. Progress in studies on central Asian foci of zoonotic cutaneous leishmaniasis: A review
155. A randomized controlled trial of insecticide-treated bednets and chaddars or top sheets, and residual spraying of interior rooms for the prevention of cutaneous leishmaniasis in Kabul, Afghanistan
156. Leishmaniasis among Desert Storm veterans: A diagnostic and therapeutic dilemma
157. Cases of cutaneous leishmaniasis infection resulting from the importation of sandflies via transportation means
158. Cutaneous leishmaniasis in expatriates in northern Saudi Arabia
159. Anthroponotic cutaneous leishmaniasis in Kabul, Afghanistan: The high susceptibility of Phlebotomus sergenti to Leishmania tropica
160. Cutaneous leishmaniasis in Kabul: Observations on a "prolonged epidemic"
161. An outbreak of cutaneous leishmaniasis in an Afghan refugee settlement in north-west Pakistan
162. Anthroponotic cutaneous leishmaniasis in Kabul, Afghanistan: Vertical distribution of cases in apartment blocks
163. Endemic foci of visceral leishmaniasis in Afghanistan
164. Kala-azar in Afghanistan
165. The current aspects of seroepidemiologic screening in combined foci of leishmaniasis
166. The endemic infectious diseases of Somalia
167. Safety, and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: Recent US military experience
168. US food and drug administration approval of AmBisome (liposomal amphotericin b) for treatment of visceral leishmaniasis
169. Editorial response: US Food and drug administration approval of AmBisome (liposomal amphotericin b) for treatment of visceral leishmaniasis
170. Leishmaniasis
171. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis
172. The contribution of sandfly control to leishmaniasis control
173. Outbreak of Crimean-Congo haemorrhagic fever in Quetta, Pakistan: Contact tracing and risk assessment
174. Ticks of small mammals from the Hindu Kush (Afghanistan)
175. Bunyaviridae: Bunyaviruses, phleboviruses, nairoviruses, and hantaviruses
176. Media reports of Congo-Crimean hemorrhagic fever, Pakistan
177. Crimean hemorrhagic fever - Congo (CHF-C) virus antibodies in man, and in domestic and small mammals, in Iran
178. Crimean-Congo hemorrhagic fever
179. The clinical pathology of Crimean-Congo hemorrhagic fever
180. Antibody response in Crimean-Congo hemorrhagic fever
181. Management of patients with suspected viral hemorrhagic fever
182. Crimean Congo hemorrhagic fever treated with oral ribavirin
183. Specific intravenous immunoglobulin for Crimean-Congo hemorrhagic fever
184. Update on management of patients with suspected viral hemorrhagic fever - United States
185. West Nile virus: A reemerging global pathogen
186. West Nile virus in Pakistan. II. Entomological studies at Changa Manga National Forest, Punjab Province
187. Seroepidemiological study of infection with West Nile virus in Karachi, Pakistan, in 1983 and 1985
188. Serological survey on viral antibodies in Iran
189. Natural focal zoonoses in Afghanistan (review of literature)
190. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000
191. The outbreak of West Nile virus infection in the New York City area in 1999
192. Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile virus infection
193. West Nile virus
194. Phlebotomus (pappataci or sandfly) fever: A disease of military importance. Summary of existing knowledge and preliminary report of original investigations
195. Studies on the epidemiology of sandfly fever in Iran. I. Virus isolates obtained from Phlebotomus
196. Studies on the epidemiology of sandfly fever in Iran. II. The prevalence of human and animal infection with five Phlebotomus fever serotypes in Isfahan Province
197. A natural focus of sandfly fever in the Republic of Afghanistan
198. Virological study of cases of sandfly fever in Afghanistan
199. Clinical and serologic responses of volunteers infected with Phlebotomus fever virus (Sicilian type)
200. Viremia and immune response with sequential phlebovirus infections
201. Virus hemorrhagic fevers
202. Hemorrhagic fever with renal syndrome in Korea
203. The protean manifestations of hemorrhagic fever with renal syndrome
204. Prospective, double blind concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome
205. Geographic distribution of Bhanja virus
206. Outbreak of arbovirus infection in the Tadzhik SSR due to the Issyk-Kul virus (Issyk-Kul fever)
207. Isolation of the virus of Syr-Darya Valley fever
208. A sero-epidemiological survey for bunyaviridae and certain other arboviruses in Pakistan
209. Respiratory diseases among US military personnel: Countering emerging threats
210. Outbreak of influenza in highly vaccinated crew of US Navy ship
211. Prolonged afebrile nonproductive cough illnesses in American soldiers in Korea: A serological search for causation
212. Pneumococcal pneumonia in military recruits
213. Pneumonia in young males in extreme conditions
214. Influenza
215. Acute respiratory infection, Afghanistan
216. Randomized, placebo-controlled trial of oral azithromycin prophylaxis against respiratory infections in a high-risk, young adult population
217. The white plague
218. Prevalence of pulmonary tuberculosis on the roof of the world
219. Progress in global tuberculosis control 1995-1996, with emphasis on 22 high-incidence countries. Global monitoring and surveillance project
220. Disintegrating health services and resurgent tuberculosis in post-Soviet Tajikistan: An example of structural violence
221. Dispatches from abroad: Aground in a sea of TB
222. Tuberculosis morbidity trends among children, adolescents and young adults in Uzbekistan
223. Tuberculosis epidemiology and disease control in Uzbekistan
224. MSF call for laboratory support
225. The problem of tuberculosis in Kyrgyzstan
226. Tuberculosis control in Kyrgyzstan - An opportunity
227. Q fever: Current concepts
228. Coxiella burnetii (Q fever)
229. Q Fever
230. Q fever meningoencephalitis in a soldier returning from the Persian Gulf War
231. Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases
232. Q Fever endocarditis
233. Antibiotic treatment of rickettsiosis, recent advances and current concepts
234. Orientia tsutsugamushi infection: Overview and immune responses
235. The occurrence of scrub typhus in unusual habitats in West Pakistan
236. Scrub typhus in West Pakistan
237. Ecological considerations in scrub typhus
238. Scrub typhus in suburban Bangkok: First cases
239. Doxycycline and rifampicin for mild scrub-typhus infections in northern Thailand: A randomised trial
240. Rickettsioses as paradigms of new or emerging infectious diseases
241. Tick-borne rickettsiae of the spotted fever group in West Pakistan. II. Serological classification of isolates from West Pakistan and Thailand: Evidence for two new species
242. Rickettsia prowazekii (epidemic or louse-borne typhus)
243. Rickettsial pathogens and their arthropod vectors
244. Rickettsia typhi (murine typhus)
245. Borrelia: Strains, vectors, human and animal borreliosis
246. Borrelia species (relapsing fever)
247. Meptazinol diminishes the Jarisch-Herxheimer reaction of relapsing fever
248. The effect of antibody against TNF-alpha on cytokine response in Jarisch-Herxheimer reactions of louse-borne relapsing fever
249. Anthrax in infants and children in Afghanistan
250. Anthrax of the eyelid
251. The specter of biologic weapons
252. Anthrax as a biologic weapon: Medical and public health management
253. Iraq's biologic weapons: The past as future?
254. The economic impact of a bioterrorist attack: Are prevention and postattack intervention programs justifiable?
255. Recognition and management of anthrax - An update
256. Anthrax: Clinical features, pathogenesis, and potential biologic warfare threat
257. Biologic warfare: A historical perspective
258. The Sverdlosk anthrax outbreak of 1979
259. Clinical recognition and management of patients exposed to biological warfare agents
260. Bioterrorism on the home front: A new challenge for American medicine
261. Index case of fatal inhalational anthrax due to bioterrorism in the United States
262. Death due to bioterrorism-related inhalational anthrax: Report of two patients
263. Clinical presentation of inhalational anthrax following bioterrorism exposure: Report of 2 surviving patients
264. Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States
265. Notice to readers: Ongoing investigation of anthrax - Florida, October 2001
266. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001
267. Recognition of illness associated with the intentional release of a biologic agent
268. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax
269. Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis
270. Update: Investigation of bioterrorism-related inhalational anthrax - Connecticut, 2001
271. Anthrax as a potential biologic warfare agent
272. Anthrax as a biological weapon, 2002
273. Anthrax
274. Anthrax
275. Anthrax
276. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001
277. Notice to readers: Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis
278. Notice to readers: Update: Interim recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax
279. Statement by the Department of Health and Human Services regarding additional options for preventive treatment for those exposed to inhalational anthrax
280. Anthrax: The disease in relation to vaccines
281. Epizootiology of leptospirosis
282. Prevalence of sand fly fever, West Nile, Crimean-Congo hemorrhagic fever, and leptospirosis antibodies in Pakistani military personnel
283. Further results of serological examination of domestic animals for leptospirosis in Afghanistan
284. Leptospirosis
285. An efficacy trial of doxycycline chemoprophylaxis against leptospirosis
286. Doxycycline therapy for leptospirosis
287. Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis
288. Recent declines in reported syphilis rates in Eastern Europe and Central Asia: Are the epidemics over?
289. The immune status of homosexuals ill with different forms of syphilis
290. Potential for HIV transmission among truck drivers in Pakistan
291. HIV infection associated with drug injecting in the newly independent states, Eastern Europe: The social and economic context of epidemics
292. Frequency of Chlarnydia trachomatis in pregnant women
293. Yersinia species
294. Yersinia species, including plague
295. Plague (Pestis)
296. Outbreak of poliomyelitis - Kunduz, Afghanistan, 1999
297. Progress toward poliomyelitis eradication - Afghanistan, 1994-1999
298. Household survey of locomotor disability caused by poliomyelitis and landmines in Afghanistan
299. Measles epidemic sweeps through Afghanistan
300. Diagnosis of measles with an IgM capture EIA: The optimal timing of specimen collection after rash onset
301. Clinical characteristics and management of 676 hospitalized diphtheria cases
302. Diphtheria in Afghanistan - Review of 155 cases
303. Universal immunization: The diphtheria control strategy of choice in the republic of Tajikistan 1993-1997
304. Diphtheria epidemic in the Republic of Uzbekistan, 1993-1996
305. Epidemic investigation of diphtheria, Republic of Kazakhstan, 1990-1996
306. Epidemic diphtheria in the Kyrgyz Republic, 1994-1998
307. Corynebacterium diphtheriae
308. Clostridium tetani (tetanus)
309. Leprosy - Global situation
310. Mycobacterium leprae (leprosy, Hansen's disease)
311. Hydatidosis: Dynamics of transmission
312. Epidemiologic aspects of echinococcus
313. The prognosis for a change in the situation of echinococcosis among the population in Uzbekistan
314. Echinococcus, Uzbekistan
315. Seroepidemiologic study of echinococcosis foci in southeastern Kazakhstan
316. Neurocysticercosis and echinococcosis in Asia: Recent advances in the establishment of highly reliable differential serodiagnosis for international collaboration
317. Echinococcosis: An emerging or re-emerging zoonosis?
318. Hydatid cyst of the lung: Diagnosis and treatment
319. Laboratory diagnosis of cystic hydatic disease
320. Molecular tools for the diagnosis of cystic and alveolar echinococcosis
321. A dynamic study of the immune response of the population in a focus of hydatid disease in Dzhambul Province, Kazakhstan
322. Treatment of hydatid disease
323. Vaccination against cysticercosis and hydatid disease